TY - JOUR
T1 - Utilization of Veno-Arterial Extracorporeal Life Support for Acute Respiratory Distress Syndrome After Liver Transplant
AU - Sheckley, Marwan
AU - Calderon, Esteban
AU - Patel, Bhavesh M.
AU - Sen, Ayan
AU - Giorgakis, Emmanouil
AU - Hewitt, Winston R.
AU - Singer, Andrew L.
AU - Reddy, Kunam S.
AU - Moss, Adyr A.
AU - Mathur, Amit K.
N1 - Funding Information:
From the 1Division of Transplant Surgery, Department of Surgery, and the 2Department of Critical Care Medicine, Mayo Clinic Hospital, Phoenix, Arizona, USA Acknowledgements: The authors have no sources of funding for this study. Amit K. Mathur has received funding from Genentech unrelated to this study. Corresponding author: Amit K. Mathur, 5777 E Mayo Blvd, Phoenix, AZ 85054, USA E-mail: mathur.amit@mayo.edu
Publisher Copyright:
© Başkent University 2022.
PY - 2022/6
Y1 - 2022/6
N2 - In this report, we present a case of successful long-term salvage of a patient with transfusion-related acute lung injury associated with acute respiratory distress syndrome immediately after a liver transplant. The patient was a 29-year-old man with end-stage liver disease due to sclerosing cholangitis who underwent liver transplant. After organ reperfusion, there was evidence of liver congestion, acidosis, coagulopathy, and acute kidney injury. He received 61 units of blood products. Continuous renal replacement therapy was initiated intraoperatively. On arrival to the intensive care unit, the patient was on high-dose pressors, and the patient developed respiratory failure and was immediately placed on veno-arterial extracorporeal membrane oxygenation via open femoral exposure. The patient presented with severe coagulopathy and early allograft dysfunction; therefore, no systemic heparin was administered and no thrombotic events occurred. He required extracorporeal membrane oxygenation support until posttransplant day 4, when resolution of the respiratory and cardiac dysfunction was noted. At 2 years after liver transplant, the patient has normal liver function, normal cognitive function, and stage V chronic kidney disease. We conclude that extracorporeal membrane oxygenation is a valuable therapeutic approach in patients with cardiorespiratory failure after liver transplant.
AB - In this report, we present a case of successful long-term salvage of a patient with transfusion-related acute lung injury associated with acute respiratory distress syndrome immediately after a liver transplant. The patient was a 29-year-old man with end-stage liver disease due to sclerosing cholangitis who underwent liver transplant. After organ reperfusion, there was evidence of liver congestion, acidosis, coagulopathy, and acute kidney injury. He received 61 units of blood products. Continuous renal replacement therapy was initiated intraoperatively. On arrival to the intensive care unit, the patient was on high-dose pressors, and the patient developed respiratory failure and was immediately placed on veno-arterial extracorporeal membrane oxygenation via open femoral exposure. The patient presented with severe coagulopathy and early allograft dysfunction; therefore, no systemic heparin was administered and no thrombotic events occurred. He required extracorporeal membrane oxygenation support until posttransplant day 4, when resolution of the respiratory and cardiac dysfunction was noted. At 2 years after liver transplant, the patient has normal liver function, normal cognitive function, and stage V chronic kidney disease. We conclude that extracorporeal membrane oxygenation is a valuable therapeutic approach in patients with cardiorespiratory failure after liver transplant.
KW - Acute kidney injury
KW - Acute lung injury
KW - End-stage liver disease
UR - http://www.scopus.com/inward/record.url?scp=85133554773&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85133554773&partnerID=8YFLogxK
U2 - 10.6002/ect.2020.0068
DO - 10.6002/ect.2020.0068
M3 - Article
C2 - 32778014
AN - SCOPUS:85133554773
SN - 1304-0855
VL - 20
SP - 616
EP - 620
JO - Experimental and Clinical Transplantation
JF - Experimental and Clinical Transplantation
IS - 6
ER -